What are clinical trials?
Clinical trials are research studies used to support our mission of finding new and better ways to treat and prevent Alzheimer’s and other neurodegenerative diseases. With the help of volunteers, our doctors are able to learn more about the disease and its risks and patients are able to have access to advanced treatments.
Once our researchers find a promising treatment, the treatment will be made available to people that meet the criteria for the particular disease being studied.
Available clinical trials
Senolytic Therapy to Modulate the Progression of Alzheimer’s Disease (SToMP-AD) Study
The purpose of this study is to evaluate if a combination of two medications, dasatinib and quercetin (also known as “senolytics”), penetrate the brain using cerebrospinal fluid (CSF) in individuals with early Alzheimer’s disease.
The purpose of this clinical trial is to collect data to study how gait patterns in older adults correlate with brain function.
Heart Function and Brain Health Study
The purpose of this clinical trial is to study heart function and brain health.
Memory Improvement Through Nicotine Dosing (MIND) Study
The purpose of this study is to determine whether nicotine (in patch form) improves memory and functioning in adults diagnosed with mild cognitive impairment (MCI).
Biggs Institute is an official partner of the Alzheimer’s Disease Cooperative Study and the University of Southern California Alzheimer’s Therapeutic Research Institute.